SCHEMBL24822650

SCHEMBL24822650

CC1CC(=O)N(CCCCCC(=O)NCC(=O)NCC(=O)N[C@@H](Cc2ccccc2)C(=O)NCC(=O)I)C1=O

nearest known ligand 0.43

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
OPRL1 P41146 4/20 0.41
FOLH1 Q04609 3/20 0.41
OPRD1 P41143 1/20 0.39
HDAC3 O15379 2/20 0.38
HDAC4 P56524 2/20 0.38
HDAC1 Q13547 2/20 0.38
HDAC7 Q8WUI4 2/20 0.38
HDAC2 Q92769 2/20 0.38
HDAC10 Q969S8 2/20 0.38
HDAC11 Q96DB2 2/20 0.38
HDAC8 Q9BY41 2/20 0.38
HDAC6 Q9UBN7 2/20 0.38
HDAC9 Q9UKV0 2/20 0.38
HDAC5 Q9UQL6 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24823232 0.93 OPRL1 (0.43) ALDH1A1SMN1; SMN2OPRL1FOLH1OPRD1
SCHEMBL27268237 0.93 OPRL1 (0.43) ALDH1A1SMN1; SMN2OPRL1FOLH1OPRD1
SCHEMBL26030700 0.93 ALDH1A1 (0.43) ALDH1A1SMN1; SMN2OPRL1FOLH1OPRD1
SCHEMBL23515709 0.93 FOLH1 (0.43) ALDH1A1SMN1; SMN2OPRL1FOLH1OPRD1
SCHEMBL27390781 0.92 OPRL1 (0.43) ALDH1A1SMN1; SMN2OPRL1FOLH1OPRD1
SCHEMBL22969978 0.92 ALDH1A1 (0.42) ALDH1A1SMN1; SMN2OPRL1FOLH1OPRD1
SCHEMBL22969979 0.88 OPRL1 (0.40) ALDH1A1SMN1; SMN2OPRL1FOLH1OPRD1
SCHEMBL23515689 0.88 OPRL1 (0.39) ALDH1A1SMN1; SMN2OPRL1FOLH1OPRD1
SCHEMBL23680160 0.87 OPRL1 (0.42) ALDH1A1SMN1; SMN2OPRL1FOLH1OPRD1
SCHEMBL17029464 0.86 FAAH (0.41) OPRL1FOLH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022268202-A1 LIGAND-DRUG CONJUGATE AND USE THEREOF 同宜医药(苏州)有限公司 2022-12-29 WO disclosed